Clinical Trials Browser

Phase 1/2 × Carcinoma, Renal Cell × pazopanib × Clear all

NCT01684397 2026-02-27

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Phase 1/2 Active not recruiting

Carcinoma, Renal Cell